Jpmorgan Chase & CO Care Dx, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Care Dx, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 48,574 shares of CDNA stock, worth $714,037. This represents 0.0% of its overall portfolio holdings.

Number of Shares
48,574
Previous 197,912 75.46%
Holding current value
$714,037
Previous $4.24 Million 79.66%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$17.64 - $25.07 $2.63 Million - $3.74 Million
-149,338 Reduced 75.46%
48,574 $862,000
Q4 2024

Feb 12, 2025
BUY
$20.4 - $32.2 $3.55 Million - $5.6 Million
173,776 Added 719.99%
197,912 $4.24 Million
Q3 2024

Dec 26, 2024
BUY
$14.41 - $33.99 $5,288 - $12,474
367 Added 1.54%
24,136 $753,000
Q3 2024

Nov 08, 2024
BUY
$14.41 - $33.99 $5,288 - $12,474
367 Added 1.54%
24,136 $753,000
Q2 2024

Dec 26, 2024
SELL
$7.56 - $16.15 $2,774 - $5,927
-367 Reduced 1.52%
23,769 $369,000
Q2 2024

Aug 12, 2024
BUY
$7.56 - $16.15 $9,843 - $21,027
1,302 Added 5.8%
23,769 $369,000
Q1 2024

Dec 26, 2024
SELL
$7.96 - $12.37 $13,285 - $20,645
-1,669 Reduced 6.91%
22,467 $237,000
Q1 2024

May 10, 2024
SELL
$7.96 - $12.37 $113,549 - $176,458
-14,265 Reduced 38.84%
22,467 $237,000
Q4 2023

Dec 26, 2024
BUY
$4.9 - $12.86 $61,720 - $161,984
12,596 Added 52.19%
36,732 $440,000
Q4 2023

Feb 12, 2024
BUY
$4.9 - $12.86 $5,252 - $13,785
1,072 Added 3.01%
36,732 $440,000
Q3 2023

Nov 14, 2023
SELL
$7.0 - $11.26 $107,723 - $173,280
-15,389 Reduced 30.15%
35,660 $249,000
Q2 2023

Aug 11, 2023
SELL
$7.61 - $9.46 $1.36 Million - $1.68 Million
-178,103 Reduced 77.72%
51,049 $433,000
Q1 2023

May 18, 2023
BUY
$8.83 - $17.61 $575,945 - $1.15 Million
65,226 Added 39.79%
229,152 $2.09 Million
Q1 2023

May 11, 2023
SELL
$8.83 - $17.61 $1.57 Million - $3.14 Million
-178,257 Reduced 52.09%
163,926 $1.5 Million
Q4 2022

Feb 13, 2023
BUY
$10.88 - $20.05 $1.21 Million - $2.23 Million
111,437 Added 48.29%
342,183 $3.91 Million
Q3 2022

Nov 14, 2022
BUY
$16.06 - $26.39 $2.57 Million - $4.22 Million
159,898 Added 225.69%
230,746 $3.93 Million
Q2 2022

Aug 11, 2022
BUY
$20.49 - $39.72 $155,478 - $301,395
7,588 Added 11.99%
70,848 $1.52 Million
Q1 2022

May 11, 2022
SELL
$28.19 - $46.6 $117,016 - $193,436
-4,151 Reduced 6.16%
63,260 $2.34 Million
Q4 2021

Feb 10, 2022
SELL
$41.2 - $73.6 $1.18 Million - $2.11 Million
-28,645 Reduced 29.82%
67,411 $3.07 Million
Q3 2021

Nov 12, 2021
BUY
$59.15 - $91.99 $5.68 Million - $8.84 Million
96,056 New
96,056 $6.09 Million

Others Institutions Holding CDNA

# of Institutions
211
Shares Held
55.8M
Call Options Held
85K
Put Options Held
33.1K
View Full List

About CareDx, Inc.

CDNA Quotes by TradingView
  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $786M
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email